Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: A randomized, double-blind, placebo-controlled trial

Circulation

Volumn 105, Issue 22, 2002, Pages 2646-2652

  Wiesli, Peter ^a   Czerwenka, Wolfgang ^a   Meniconi, Alfredo ^a   Maly, Friedrich E ^b   Hoffmann, Ulrich ^a   Vetter, Wilhelm ^a   Schulthess, Georg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Angioplasty; Atherosclerosis; Carotid artery

Indexed keywords

MACROLIDE; PLACEBO; ROXITHROMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOLLOW UP; HUMAN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SECONDARY PREVENTION; SERODIAGNOSIS; WALKING;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIARRHEA; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; HUMANS; INTERLEUKIN-6; MALE; PERIPHERAL VASCULAR DISEASES; REGRESSION ANALYSIS; RISK FACTORS; ROXITHROMYCIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WALKING;

EID: 0037024326     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000017862.08503.15     Document Type: Article

References (17)

1. Atherosclerosis: An inflammatory disease
2. Chronic infections and coronary heart disease: Is there a link?
3. The progression of lower limb atherosclerosis is associated with IgA antibodies against Chlamydia pneumoniae
4. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
5. Rabbit model for Chlamydia pneumoniae infection
6. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: The Chlamydia pneumoniae/Atherosclerosis Study Group
7. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
8. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study
9. Randomized secondary prevention trial of azithromycin in patients with coronary disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease. Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
10. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease
11. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): A randomised, doubleblind, placebo-controlled trial
12. Chlamydia pneumoniae seropositivity and hyperhomocysteinemia are linked in patients with atherosclerosis
13. Dose-dependent effect of aspirin on carotid atherosclerosis
14. Management of peripheral arterial disease (PAD)
15. Spontaneous progression and regression of small carotid atheroma
16. Anti-inflammatory activity of macrolide antibiotics
17. Chlamydia pneumoniae eradiation from carotid plaques: Results of an open, randomised treatment study